Date published: 2025-10-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

V1RG4 Inhibitors

V1RG4 inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of the V1RG4 protein, which is a component of the vacuolar-type H+-ATPase (V-ATPase) complex. The V-ATPase is a multi-subunit enzyme complex responsible for generating a proton gradient across membranes in various intracellular compartments, such as endosomes, lysosomes, and vacuoles. The V1RG4 protein is a part of the V1 domain of this complex, which is integral to the hydrolysis of ATP, the process that powers the proton pump. This domain is crucial for the assembly and operation of the V-ATPase, ensuring that it can effectively transport protons across cellular membranes and maintain the acidic environment necessary for various cellular processes.

The primary action of V1RG4 inhibitors involves binding specifically to the V1RG4 protein and disrupting its function within the V1 domain of the V-ATPase complex. By targeting V1RG4, these inhibitors can interfere with the assembly, stability, or activity of the V1 domain, thereby impairing the complex's ability to hydrolyze ATP and pump protons. This inhibition affects the proton gradient and pH balance within the intracellular compartments that rely on V-ATPase activity. Studying V1RG4 inhibitors offers valuable insights into the role of V1RG4 in V-ATPase function and helps elucidate how disruptions in this protein impact cellular pH regulation and proton transport mechanisms.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Dantrolene

7261-97-4sc-500165
25 mg
$350.00
7
(0)

Dantrolene inhibits calcium release from the sarcoplasmic reticulum, potentially reducing intracellular calcium levels and inhibiting the calcium-dependent signaling pathways involved in V1R76 expression.

EGTA

67-42-5sc-3593
sc-3593A
sc-3593B
sc-3593C
sc-3593D
1 g
10 g
100 g
250 g
1 kg
$20.00
$62.00
$116.00
$246.00
$799.00
23
(1)

EGTA is a calcium chelator that reduces intracellular calcium levels, potentially inhibiting the calcium-dependent signaling pathways involved in V1R76 expression.